ClinicalTrials.gg
CompletedNCT03427190APSOMUpdated Jan 28, 2021

Suicide Prevention Algorithm in the French Overseas Territories

An interventional study of APSOM vs Control in Suicide Attempt, sponsored by University Hospital Center of Martinique. Completed at 9 sites in 4 countries. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2021-01-28.

Sponsored by University Hospital Center of Martinique · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
259
Allocation
Randomized
Ages
16 Years and older
Sex
All
01

Study summary

In France, suicide behaviours are a major public health concern that triggered the creation in 2013 of a National Observatory of Suicide. In continental France, the "Algos" protocol was found to be effective for the prevention of suicide attempts reiterations. This protocol is based on a procedure that keeps telephone and postal contacts with the suicide attempter and allows, via an algorithm, to assess the risk of suicide attempt recurrence, in order to intervene if necessary. Nevertheless, Algos does not involve primary care health practitioners, who could add a substantial additional efficacy, especially if they intervene downstream and in supplement to Algos. In addition, this kind of protocol has never been evaluated in the French overseas territories.

Read the detailed description

Since (1) Algos was never implemented in the French overseas departments (FOD) and does not involve primary care practitioners (PCP), (2) the additional effect of PCP involvement over and beyond Algos alone in unknown, and (3) little research on suicide behaviours has been conducted in the FOD, this proposal has the following main aim: to assess the effectiveness and the efficacy of the intervention, in supplement and downstream to Algos, of a healthcare professional, on the recurrence of suicide attempts in the FOD; the healthcare professional will be the patient's general practitioner, whenever possible.

02

Conditions studied

  • Suicide Attempt

Keywords

  • Suicide
  • Suicide attempted
  • Secondary Prevention
  • Relapse prevention
  • Case Management
  • Intervention Study
03

In context

Suicide, Attempted

281 studies on the registry are indexed under Suicide, Attempted; 91 are open to participants now.

This study's enrollment of 259 is above the median of 129 across 224 interventional studies indexed under Suicide, Attempted.

Browse Suicide, Attempted studies →

Lead sponsor

University Hospital Center of Martinique is the lead sponsor of 79 studies on the registry; 21 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Man or woman over 16 years of age
  • Leaving the hospital within 15 days of the suicide attempt
  • Giving (him/herself or his/her legal representative)an oral consent to participate in the study
  • Having healthcare insurance
  • Reachable by phone, with possibility of confidential conversation, and by mail
  • Resident of Guadeloupe, French Guyana, Martinique, or Reunion Island
  • Able to understand and speak French

Exclusion criteria

Exclusion Criteria:

  • Homeless person
  • Disabled adult, person under judicial/court protection, legally incompetent adult
  • Participant unable to understand the study protocol, its risks and side effects, or declining to participate
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
259 participants (actual)

Study arms

  • Active comparator
    Control

    Phone contact with patient will be made by a professional psychologist within 21 days of hospital discharge. If contact cannot be made after 9 attempts, post-cards will be sent monthly at M2, M3, M4 and M5, asking the participant to establish contact with the designated psychologist. The phone call will determine whether or not the participant is in a state of suicidal crisis. If yes, steps will be taken to attend the crisis within 24 hours.

    Other: APSOM vs Control

  • Other
    APSOM

    In complement to actions described in the control arm, the patient's general practitioner (GP) and the patient him/herself will be contacted within 21 days of hospital discharge in order to organize an appointment between them two; this consultation is expected to take place between day 22 and day 45 after hospital discharge. If the patient does not have a GP, a health-care professional (HCP) will be provided. .GP (or HCP) will also be contacted at 6 and 13 months.

    Other: APSOM vs Control

Interventions

  • OtherAPSOM vs Control

    In complement to actions described in the control arm, the patient's general practitioner (GP) and the patient him/herself will be contacted within 21 days of hospital discharge in order to organize an appointment between them two; this consultation is expected to take place between day 22 and day 45 after hospital discharge. If the patient does not have a GP, a health-care professional (HCP) will be provided. .GP (or HCP) will also be contacted at 6 and 13 months.

06

What researchers measure

Primary outcomes

  1. Existence of a suicide

    Reiteration of suicidal attempt after hospital discharge

    Time frame: 6 months

  2. Existence of a suicide

    Reiteration of suicidal attempt after hospital discharge

    Time frame: 13 months

Secondary outcomes

  1. Number of suicide attempts

    To know total number of suicide

    Time frame: 6 and 13 months after hospital discharge

  2. Number of deaths by suicide

    To know number of deaths by suicide

    Time frame: 6 and 13 months after hospital discharge

  3. Scores at the Hospital Anxiety and Depression Scale (HADS)

    Pass the scale HADS

    Time frame: 6 and 13 months after hospital discharge

  4. Assessment of suicidal risk by the Sad Persons Scale and the Columbia Suicide Severity Rating Scale (C-SSRS).

    Pass the scale Columbia

    Time frame: 6 and 13 months after hospital discharge

07

Study locations

9 sites
  • CH de Cayenne
    Cayenne, 97306, French Guiana
  • CH Ouest Guyanais
    Saint-Laurent du Maroni, 97393, French Guiana
  • CHU de Pointe à Pitre
    Les Abymes, 97189, Guadeloupe
  • CH de Monteran
    Saint-claude, 97120, Guadeloupe
  • CHU Martinique
    Fort-de-France, 97261, Martinique
  • Etablissement Psychiatrique de Santé Mentale
    Saint-Benoit, 97470, Réunion
  • Centre d'Accueil Psychiatrique Nord
    Saint-denis, 97405, Réunion
  • Centre d'Accueil Psychiatrique Ouest-Centre
    Saint-Paul, 97863, Réunion
  • Centre d'Accueil d'Urgences Médico-Psychologique
    Saint-Pierre, 97448, Réunion
08

References and documents

Publications

  • Witt KG, Hetrick SE, Rajaram G, Hazell P, Taylor Salisbury TL, Townsend E, Hawton K. Psychosocial interventions for self-harm in adults. Cochrane Database Syst Rev. 2021 Apr 22;4(4):CD013668. doi: 10.1002/14651858.CD013668.pub2. PubMed 33884617 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2017 to primary completion in Aug 2019, 21 months.

Of 145 non-industry interventional studies with no phase under Suicide, Attempted, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 21 and three quarters within 56. This study's 21 months is below that.

Counting every sponsor, half of 147 studies reached it within 37 months; a quarter within 20 and three quarters within 56.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 30, 2017
First posted
Feb 9, 2018
StartActual
Oct 9, 2017
Primary completionActual
Aug 8, 2019
CompletionActual
Oct 16, 2020
Last update
Jan 28, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 28, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03427190
Lead sponsor
University Hospital Center of Martinique
Collaborators
Centre Hospitalier de Monteran, Guadeloupe, Centre Hospitalier Universitaire de la Guadeloupe, Centre Hospitalier de Cayenne, Centre Hospitalier de Ouest Guyanais Franck Joly, Centre d Accueil Psychiatrique Ouest-Centre, La Réunion, Centre d Accueil d Urgences Médico Psychologique, La Réunion, Centre d Accueil Psychiatrique Nord, La Réunion, Etablissement Publique de Santé Mentale de la Réunion
Responsible party
Sponsor
First posted
Feb 9, 2018
Start date
Oct 9, 2017
Primary completion
Aug 8, 2019
Completion
Oct 16, 2020
Last update
Jan 28, 2021

Study contacts

JEHEL Louis, MD-PhD
principal investigator · CHU de Martinique

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion